Target Host Epigenetic Regulation of HIV Proviruses to Reinforce Viral Deep Latency in Microglia

HIV原病毒的靶宿主表观遗传调控可增强小胶质细胞中病毒的深潜伏期

基本信息

  • 批准号:
    10748760
  • 负责人:
  • 金额:
    $ 78.87万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-07-01 至 2028-04-30
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY The global rate of HIV infection and the number of AIDS related deaths have dramatically declined due to the expanding access to combinatorial anti-retroviral therapy (cART). However, the HIV epidemic remains and there is still no cure for HIV infection. Because cART does not eradicate HIV, while replication-competent viruses become integrated and silenced proviruses, which can be sporadically reactivated to replenish viral reservoirs. As a key anatomical “sanctuary site” for HIV infection and persistence/latency, reservoirs in brain remains a main hurdle for HIV cure. HIV-infected monocytes contribute to viral spread from the periphery blood to the brain as they can migrate across the blood brain barrier (BBB) and differentiate into microglia in the central nervous system (CNS). Microglia are a major and stable viral reservoir for persistent/latent HIV infection in the CNS, even in the presence of cART. Furthermore, HIV-infected microglia release neurotoxic factors that promote neuroinflammation and contribute to HIV-associated neurocognitive disorders (HAND). Therefore, characterization of molecular features regulating HIV persistent/latent infection in microglia is essential for developing effective intervention strategies to control and inhibit HIV in the CNS. Epigenetic regulation critically determines the faith of HIV proviruses and contributes significantly to HIV latency. The focus of this project is to investigate the role of host epigenetic regulation in promoting persistent/latent HIV infection in microglia and target it for preventing HIV lytic reactivation. We have identified a set of Jumonji domain-containing histone lysine demethylases (KDMs) as HIV latency-promoting genes (LPGs) that preferentially target histone H3K4/K36 methylation (H3K4/K36me3), which indicates the potential role of histone demethylation in regulation of HIV latency. In Aim 1, we will investigate the contribution of these KDMs to promoting HIV latency in human microglia and iPSC-derived microglia containing organoids (MCOs). In Aim 2, encouraged by the KDM studies, we would like to continue the use of our functional genomic and proteomic expertise to identify other ovel host factors governing HIV latency in microglia by multidisciplinary approaches, including single-cell CRISPR screen. This is an important issue to address so that we can novel host targets to develop more potent regimen for reinforcing HIV latency and preventing its resurrection at a cART-free setting in microglia. Furthermore, we also screened a library of FDA-approved drugs and identify HIV latency- promoting agents (LPAs), including levosimendan (LSM). In Aim 3, we propose the translational studies to investigate the repurposing of FDA-approved drugs already used in clinic for treating and blocking HIV persistent/latent infection in microglia, which likely affect epigenetic processes.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

WENZHE HO其他文献

WENZHE HO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('WENZHE HO', 18)}}的其他基金

Effect of Methamphetamine and/or HIV on Human iPSCs-derived microglia and Neuron
甲基苯丙胺和/或 HIV 对人 iPSC 衍生的小胶质细胞和神经元的影响
  • 批准号:
    10210377
  • 财政年份:
    2020
  • 资助金额:
    $ 78.87万
  • 项目类别:
HIV, Methamphetamine and Human iPSC-derived Microglia-containing Cerebral Organoids
HIV、甲基苯丙胺和人类 iPSC 衍生的含有小胶质细胞的大脑类器官
  • 批准号:
    10611364
  • 财政年份:
    2020
  • 资助金额:
    $ 78.87万
  • 项目类别:
Effect of Methamphetamine and/or HIV on Human iPSCs-derived microglia and Neuron
甲基苯丙胺和/或 HIV 对人 iPSC 衍生的小胶质细胞和神经元的影响
  • 批准号:
    10031319
  • 财政年份:
    2020
  • 资助金额:
    $ 78.87万
  • 项目类别:
HIV, Methamphetamine and Human iPSC-derived Microglia-containing Cerebral Organoids
HIV、甲基苯丙胺和人 iPSC 衍生的含有小胶质细胞的大脑类器官
  • 批准号:
    10205018
  • 财政年份:
    2020
  • 资助金额:
    $ 78.87万
  • 项目类别:
HIV, Methamphetamine and Human iPSC-derived Microglia-containing Cerebral Organoids
HIV、甲基苯丙胺和人 iPSC 衍生的含有小胶质细胞的大脑类器官
  • 批准号:
    10398189
  • 财政年份:
    2020
  • 资助金额:
    $ 78.87万
  • 项目类别:
HIV, Methamphetamine and Human iPSC-derived Microglia-containing Cerebral Organoids
HIV、甲基苯丙胺和人类 iPSC 衍生的含有小胶质细胞的大脑类器官
  • 批准号:
    10055449
  • 财政年份:
    2020
  • 资助金额:
    $ 78.87万
  • 项目类别:
Role of miRNAs in Methamphetamine/HIV-mediated Immune Activation
miRNA 在甲基苯丙胺/HIV 介导的免疫激活中的作用
  • 批准号:
    10357940
  • 财政年份:
    2018
  • 资助金额:
    $ 78.87万
  • 项目类别:
Opioids, Extracellular Vesicles and BBB Innate Immunity
阿片类药物、细胞外囊泡和 BBB 先天免疫
  • 批准号:
    9381158
  • 财政年份:
    2017
  • 资助金额:
    $ 78.87万
  • 项目类别:
Opioids, Extracellular Vesicles and BBB Innate Immunity
阿片类药物、细胞外囊泡和 BBB 先天免疫
  • 批准号:
    9485926
  • 财政年份:
    2017
  • 资助金额:
    $ 78.87万
  • 项目类别:
Methamphetamine, Innate Immunity and HIV
甲基苯丙胺、先天免疫和艾滋病毒
  • 批准号:
    9308910
  • 财政年份:
    2016
  • 资助金额:
    $ 78.87万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 78.87万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 78.87万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 78.87万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 78.87万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 78.87万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 78.87万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 78.87万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 78.87万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 78.87万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 78.87万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了